Cargando…

Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)

Dyslipidemia in patients with type 2 diabetes (DMT2) is one of the worst controlled worldwide, with only about 1/4 of patients being on the low-density lipoprotein cholesterol (LDL-C) target. There are many reasons of this, including physicians’ inertia, including diabetologists and cardiologists, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banach, Maciej, Surma, Stanisław, Reiner, Zeljko, Katsiki, Niki, Penson, Peter E., Fras, Zlatko, Sahebkar, Amirhossein, Paneni, Francesco, Rizzo, Manfredi, Kastelein, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706947/ https://www.ncbi.nlm.nih.gov/pubmed/36443827 http://dx.doi.org/10.1186/s12933-022-01684-5

Ejemplares similares

Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia
por: Banach, Maciej, et al.
Publicado: (2021)

Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?
por: Surma, Stanisław, et al.
Publicado: (2022)

Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
por: Banach, Maciej, et al.
Publicado: (2020)

Nutrition, Nutraceuticals and Bioactive Compounds in the Prevention and Fight against Inflammation
por: Surma, Stanisław, et al.
Publicado: (2023)

Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials
por: Sahebkar, Amirhossein, et al.
Publicado: (2018)

CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and Opportunities
por: Walker, Harry E., et al.
Publicado: (2021)

Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis
por: Reiner, Željko, et al.
Publicado: (2019)

2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy
por: Banach, Maciej, et al.
Publicado: (2022)

Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia
por: Sosnowska, Bożena, et al.
Publicado: (2022)

Challenges and Opportunities on Lipid Metabolism Disorders Diagnosis and Therapy: Novel Insights and Future Perspective
por: Fras, Zlatko, et al.
Publicado: (2021)

2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
por: Banach, Maciej, et al.
Publicado: (2023)

Effects of statins on the incidence and outcomes of acute kidney injury in critically ill patients: a systematic review and meta-analysis
por: Vahedian-Azimi, Amir, et al.
Publicado: (2023)

A look to the past – what has had the biggest impact on lipids in the last four decades? A personal perspective
por: Banach, Maciej, et al.
Publicado: (2023)

The role of statins in lung cancer
por: Amin, Fatemeh, et al.
Publicado: (2021)

RNA Silencing in the Management of Dyslipidemias
por: Henney, Neil C., et al.
Publicado: (2021)

Statins as anti-pyroptotic agents
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2023)

The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review
por: Maierean, Serban, et al.
Publicado: (2017)

On the present and future role of Lp-PLA(2) in atherosclerosis-related cardiovascular risk prediction and management
por: Fras, Zlatko, et al.
Publicado: (2020)

The Effects of Statin Treatment on Serum Ferritin Levels: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
por: Cicero, Arrigo F.G., et al.
Publicado: (2017)

Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies
por: Surma, Stanisław, et al.
Publicado: (2021)

Dietary salt intake and atherosclerosis: an area not fully explored
por: Banach, Maciej, et al.
Publicado: (2023)

The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu
por: Mahdavi Gorabi, Armita, et al.
Publicado: (2019)

The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis
por: Dehnavi, Sajad, et al.
Publicado: (2019)

A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
por: Serban, Corina, et al.
Publicado: (2015)

Response letter: Management of statin‐induced myopathies: Much demands and still (almost) empty hands!
por: Sahebkar, Amirhossein, et al.
Publicado: (2017)

A Greater Flavonoid Intake Is Associated with Lower Total and Cause-Specific Mortality: A Meta-Analysis of Cohort Studies
por: Mazidi, Mohsen, et al.
Publicado: (2020)

More Good News on Statins and COVID-19
por: Katsiki, Niki, et al.
Publicado: (2021)

Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient!
por: Katsiki, Niki, et al.
Publicado: (2019)

Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic
por: Katsiki, Niki, et al.
Publicado: (2020)

COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
por: Surma, Stanisław, et al.
Publicado: (2021)

Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy
por: Sosnowska, Bożena, et al.
Publicado: (2022)

The impact of nuts consumption on glucose/insulin homeostasis and inflammation markers mediated by adiposity factors among American adults
por: Mazidi, Mohsen, et al.
Publicado: (2018)

Monounsaturated Fatty Acid Levels May Not Affect Cardiovascular Events: Results From a Mendelian Randomization Analysis
por: Mazidi, Mohsen, et al.
Publicado: (2020)

Longer sleep duration may negatively affect renal function
por: Mazidi, Mohsen, et al.
Publicado: (2020)

Omega-6 fatty acids and the risk of cardiovascular disease: insights from a systematic review and meta-analysis of randomized controlled trials and a Mendelian randomization study
por: Mazidi, Mohsen, et al.
Publicado: (2021)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
por: Reiner, Željko, et al.
Publicado: (2020)

Exosomes as nanocarriers for siRNA delivery: paradigms and challenges
por: Shahabipour, Fahimeh, et al.
Publicado: (2016)

The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis
por: Sahebkar, Amirhossein, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fco9q60cksfsa1shr7r0gp0qc2